Skip to main content
Erschienen in: Familial Cancer 1/2007

01.03.2007 | Original Paper

The natural history of a combined defect in MSH6 and MUTYH in a HNPCC family

verfasst von: Marjo van Puijenbroek, Maartje Nielsen, Tjitske H. C. M. Reinards, Marjan M. Weiss, Anja Wagner, Yvonne M. C. Hendriks, Hans F. A. Vasen, Carli M. J. Tops, Juul Wijnen, Tom van Wezel, Frederik J. Hes, Hans Morreau

Erschienen in: Familial Cancer | Ausgabe 1/2007

Einloggen, um Zugang zu erhalten

Abstract

In the inherited syndromes, MUTYH-associated polyposis (MAP) and hereditary nonpolyposis colorectal cancer (HNPCC), somatic mutations occur due to loss of the caretaker function that base-repair (BER) and mismatch repair (MMR) genes have, respectively. Recently, we identified a large branch from a MSH6 HNPCC family in which 19 family members are heterozygous or compound heterozygous for MUTYH germ line mutations. MSH6/MUTYH heterozygote mutation carriers display a predominant HNPCC molecular tumour phenotype, with microsatellite instability and under-representation of G>T transversions. A single unique patient is carrier of the MSH6 germline mutation and is compound heterozygote for MUTYH. Unexpectedly, this patient has an extremely mild clinical phenotype with sofar only few adenomas at age 56. Four out of five adenomas show characteristic G>T transversions in APC and/or KRAS2, as seen in MUTYH associated polyposis. No second hit of MSH6 is apparent in any of the adenomas, due to retained MSH6 nuclear expression and a lack of microsatellite instability. Although this concerns only one case, we argue that the chance to find an additional one is extremely small and currently a mouse model with this genotype combination is not available. Moreover, the patients brother who is also compound heterozygous for MUTYH but lacks the MSH6 germline mutation presented with a full blown polyposis coli. In conclusion, these data would support the notion that abrogation of both MSH6 DNA mismatch repair and base repair might be mutually exclusive in humans.
Literatur
1.
Zurück zum Zitat Al Tassan N, Chmiel NH, Maynard J et al (2002) Inherited variants of MYH associated with somatic G:C→T:A mutations in colorectal tumours. Nat Genet 30:227–232PubMedCrossRef Al Tassan N, Chmiel NH, Maynard J et al (2002) Inherited variants of MYH associated with somatic G:C→T:A mutations in colorectal tumours. Nat Genet 30:227–232PubMedCrossRef
2.
Zurück zum Zitat Lynch HT, Smyrk T (1996) Hereditary nonpolyposis colorectal cancer; an updated review. Cancer 78:1149–1167PubMedCrossRef Lynch HT, Smyrk T (1996) Hereditary nonpolyposis colorectal cancer; an updated review. Cancer 78:1149–1167PubMedCrossRef
3.
Zurück zum Zitat Cunningham JM, Christensen ER, Tester DJ (1998) Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability. Cancer Res 58:3455–3460PubMed Cunningham JM, Christensen ER, Tester DJ (1998) Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability. Cancer Res 58:3455–3460PubMed
4.
5.
Zurück zum Zitat Peltomaki P (2001) Deficient DNA mismatch repair; a common etiologic factor for colon cancer. Hum Mol Genet 10:735–740PubMedCrossRef Peltomaki P (2001) Deficient DNA mismatch repair; a common etiologic factor for colon cancer. Hum Mol Genet 10:735–740PubMedCrossRef
6.
Zurück zum Zitat Lipton L, Halford SE, Johnson V et al (2003) Carcinogenesis in MYH-associated polyposis follows a distinct genetic pathway. Cancer Res 63:7595–7599PubMed Lipton L, Halford SE, Johnson V et al (2003) Carcinogenesis in MYH-associated polyposis follows a distinct genetic pathway. Cancer Res 63:7595–7599PubMed
7.
Zurück zum Zitat Jones S, Emmerson P, Maynard J et al (2002) Biallelic germline mutations in MYH predispose to multiple colorectal adenoma and somatic G:C→T:A mutations. Hum Mol Genet 11:2961–2967PubMedCrossRef Jones S, Emmerson P, Maynard J et al (2002) Biallelic germline mutations in MYH predispose to multiple colorectal adenoma and somatic G:C→T:A mutations. Hum Mol Genet 11:2961–2967PubMedCrossRef
8.
Zurück zum Zitat Oliveira C, Westra JL, Arango D et al (2004) Distinct patterns of KRAS mutations in colorectal carcinomas according to germline mismatch repair defects and hMLH1 methylation status. Hum Mol Genet 13:2303–2311PubMedCrossRef Oliveira C, Westra JL, Arango D et al (2004) Distinct patterns of KRAS mutations in colorectal carcinomas according to germline mismatch repair defects and hMLH1 methylation status. Hum Mol Genet 13:2303–2311PubMedCrossRef
9.
Zurück zum Zitat Huang J, Papadopoulos N, McKinley AJ et al (1996) APC mutations in colorectal tumours with mismatch repair deficiency. Proc Natl Acad Sci USA 93:9049–9054PubMedCrossRef Huang J, Papadopoulos N, McKinley AJ et al (1996) APC mutations in colorectal tumours with mismatch repair deficiency. Proc Natl Acad Sci USA 93:9049–9054PubMedCrossRef
10.
Zurück zum Zitat Mazurek A, Berardini M, Fishel R (2002) Activation of human MutS homologs by 8-oxo-guanine DNA damage. J Biol Chem 277:8260–8266PubMedCrossRef Mazurek A, Berardini M, Fishel R (2002) Activation of human MutS homologs by 8-oxo-guanine DNA damage. J Biol Chem 277:8260–8266PubMedCrossRef
11.
Zurück zum Zitat Gu YS, Parker A, Wilson TM, Bai HB, Chang DY, Lu AL (2002) Human MutY homolog, a DNA glycosylase involved in base excision repair, physically and functionally interacts with mismatch repair proteins human MutS homolog 2/human MutS homolog 6. J Biol Chem 277:11135–11142PubMedCrossRef Gu YS, Parker A, Wilson TM, Bai HB, Chang DY, Lu AL (2002) Human MutY homolog, a DNA glycosylase involved in base excision repair, physically and functionally interacts with mismatch repair proteins human MutS homolog 2/human MutS homolog 6. J Biol Chem 277:11135–11142PubMedCrossRef
12.
Zurück zum Zitat Wagner A, Hendriks Y, Meijers-Heijboer EJ et al (2001) A typical HNPCC owing to MSH6 germline mutations: analysis of a large Dutch pedigree. J Med Genet 38:318–322PubMedCrossRef Wagner A, Hendriks Y, Meijers-Heijboer EJ et al (2001) A typical HNPCC owing to MSH6 germline mutations: analysis of a large Dutch pedigree. J Med Genet 38:318–322PubMedCrossRef
13.
Zurück zum Zitat Wijnen J, de Leeuw W, Vasen H et al (1999) Familial endometrial cancer in female carriers of MSH6 germline mutations. Nat Genet 23:142–144PubMedCrossRef Wijnen J, de Leeuw W, Vasen H et al (1999) Familial endometrial cancer in female carriers of MSH6 germline mutations. Nat Genet 23:142–144PubMedCrossRef
14.
Zurück zum Zitat Nielsen M, Franken PF, Reinards THCM et al (2005) Multiplicity in polyp count and extracolonic manifestations in 40 Dutch patients with MYH associated polyposis coli (MAP). J Med Genet 42:e54 Nielsen M, Franken PF, Reinards THCM et al (2005) Multiplicity in polyp count and extracolonic manifestations in 40 Dutch patients with MYH associated polyposis coli (MAP). J Med Genet 42:e54
15.
Zurück zum Zitat De Jong AE, van Puijenbroek M, Hendriks Y et al (2004) Microsatellite instability, immunohistochemistry, and additional PMS2 staining in suspected hereditary nonpolyposis colorectal cancer. Clin Cancer Res 10:972–980PubMedCrossRef De Jong AE, van Puijenbroek M, Hendriks Y et al (2004) Microsatellite instability, immunohistochemistry, and additional PMS2 staining in suspected hereditary nonpolyposis colorectal cancer. Clin Cancer Res 10:972–980PubMedCrossRef
16.
Zurück zum Zitat Nielsen M, Poley JW, Verhoef S et al (2006) Duodenal carcinoma in MUTYH-associated polyposis coli. J Clin Pathol (in press) Nielsen M, Poley JW, Verhoef S et al (2006) Duodenal carcinoma in MUTYH-associated polyposis coli. J Clin Pathol (in press)
17.
Zurück zum Zitat Van Puijenbroek M, Dierssen JW, Stanssens P et al (2005) Mass spectrometry-based loss of heterozygosity analysis of single-nucleotide polymorphism loci in paraffin embedded tumours using the MassEXTEND assay: single-nucleotide polymorphism loss of heterozygosity analysis of the protein tyrosine phosphatase receptor type J in familial colorectal cancer. J Mol Diagn 7:623–630PubMed Van Puijenbroek M, Dierssen JW, Stanssens P et al (2005) Mass spectrometry-based loss of heterozygosity analysis of single-nucleotide polymorphism loci in paraffin embedded tumours using the MassEXTEND assay: single-nucleotide polymorphism loss of heterozygosity analysis of the protein tyrosine phosphatase receptor type J in familial colorectal cancer. J Mol Diagn 7:623–630PubMed
18.
Zurück zum Zitat Parker A, Gu Y, Mahoney W, Lee SH, Singh KK, Lu AL (2001) Human homolog of the MutY repair protein (hMYH) physically interacts with proteins involved in long patch DNA base excision repair. J Biol Chem 276:5547–5555PubMedCrossRef Parker A, Gu Y, Mahoney W, Lee SH, Singh KK, Lu AL (2001) Human homolog of the MutY repair protein (hMYH) physically interacts with proteins involved in long patch DNA base excision repair. J Biol Chem 276:5547–5555PubMedCrossRef
19.
Zurück zum Zitat Croitoru ME, Cleary SP, Di Nicola N et al (2004) Association between biallelic and monoallelic germline MYH gene mutations and colorectal cancer risk. J Natl Cancer Inst 96:1631–1634PubMedCrossRef Croitoru ME, Cleary SP, Di Nicola N et al (2004) Association between biallelic and monoallelic germline MYH gene mutations and colorectal cancer risk. J Natl Cancer Inst 96:1631–1634PubMedCrossRef
20.
Zurück zum Zitat Kambara T, Whitehall VL, Spring KJ et al (2004) Role of inherited defects of MYH in the development of sporadic colorectal cancer. Genes Chromosomes Cancer 40:1–9PubMedCrossRef Kambara T, Whitehall VL, Spring KJ et al (2004) Role of inherited defects of MYH in the development of sporadic colorectal cancer. Genes Chromosomes Cancer 40:1–9PubMedCrossRef
21.
Zurück zum Zitat Niessen RC, Sijmons RH, Ou J et al (2006) MUTYH and the mismatch repair system: partners in crime? Hum Genet 119:206–211PubMedCrossRef Niessen RC, Sijmons RH, Ou J et al (2006) MUTYH and the mismatch repair system: partners in crime? Hum Genet 119:206–211PubMedCrossRef
22.
Zurück zum Zitat Soravia C, DeLozier CD, Dobbie Z et al (2005) Double frameshift mutations in APC and MSH2 in the same individual. Int J Colorectal Dis 20:466–470PubMedCrossRef Soravia C, DeLozier CD, Dobbie Z et al (2005) Double frameshift mutations in APC and MSH2 in the same individual. Int J Colorectal Dis 20:466–470PubMedCrossRef
Metadaten
Titel
The natural history of a combined defect in MSH6 and MUTYH in a HNPCC family
verfasst von
Marjo van Puijenbroek
Maartje Nielsen
Tjitske H. C. M. Reinards
Marjan M. Weiss
Anja Wagner
Yvonne M. C. Hendriks
Hans F. A. Vasen
Carli M. J. Tops
Juul Wijnen
Tom van Wezel
Frederik J. Hes
Hans Morreau
Publikationsdatum
01.03.2007
Verlag
Kluwer Academic Publishers
Erschienen in
Familial Cancer / Ausgabe 1/2007
Print ISSN: 1389-9600
Elektronische ISSN: 1573-7292
DOI
https://doi.org/10.1007/s10689-006-9103-y

Weitere Artikel der Ausgabe 1/2007

Familial Cancer 1/2007 Zur Ausgabe

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

CAR-M-Zellen: Warten auf das große Fressen

22.05.2024 Onkologische Immuntherapie Nachrichten

Auch myeloide Immunzellen lassen sich mit chimären Antigenrezeptoren gegen Tumoren ausstatten. Solche CAR-Fresszell-Therapien werden jetzt für solide Tumoren entwickelt. Künftig soll dieser Prozess nicht mehr ex vivo, sondern per mRNA im Körper der Betroffenen erfolgen.

Blutdrucksenkung könnte Uterusmyome verhindern

Frauen mit unbehandelter oder neu auftretender Hypertonie haben ein deutlich erhöhtes Risiko für Uterusmyome. Eine Therapie mit Antihypertensiva geht hingegen mit einer verringerten Inzidenz der gutartigen Tumoren einher.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.